Medicare Enrolled

Dr. Sonal Sethi, M.D

Medical Oncology · Pearland, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
10970 SHADOW CREEK PKWY, Pearland, TX 77584
7134367500
In practice since 2007 (18 years)
NPI: 1437348281 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sethi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sethi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sethi

Dr. Sonal Sethi is a medical oncology specialist in Pearland, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Sethi performed 11,955 Medicare services across 510 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sethi received a total of $3,530 from 43 pharmaceutical and/or device companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sethi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 40% volume in TX $3,530 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,955
Medicare services
Top 40% in TX for medical oncology
510
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~664 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
10,710 $0 $5
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
308 $8 $20
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
290 $8 $36
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
151 $59 $250
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
134 $10 $64
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
87 $96 $368
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
56 $11 $96
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
50 $61 $247
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
41 $50 $313
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
40 $23 $157
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
37 $103 $707
New patient office visit, complex (60-74 min) 25 $153 $709
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
15 $6 $31
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
11 $129 $694
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
90.6% high complexity
0.5% medium
9.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,530
Total received (2018-2024)
Avg $504/year across 7 years
Bottom 48% in TX for medical oncology
43
Companies
153
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,207 (90.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$323 (9.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$943
2023
$1,804
2022
$559
2021
$12
2020
$27
2019
$71
2018
$115

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$350
Novartis Pharmaceuticals Corporation
$330
PFIZER INC.
$293
Merck Sharp & Dohme LLC
$201
Janssen Biotech, Inc.
$197
PharmaEssentia USA Corporation
$194
GENZYME CORPORATION
$184
Amgen Inc.
$161
E.R. Squibb & Sons, L.L.C.
$137
Gilead Sciences, Inc.
$123
AstraZeneca Pharmaceuticals LP
$103
Astellas Pharma US Inc
$97
Karyopharm Therapeutics Inc.
$81
BeiGene USA, Inc.
$66
Puma Biotechnology, Inc.
$63
PUMA BIOTECHNOLOGY, INC.
$60
Takeda Pharmaceuticals U.S.A., Inc.
$57
AVEO Pharmaceuticals, Inc.
$54
Exelixis Inc.
$54
Daiichi Sankyo Inc.
$54
Deciphera Pharmaceuticals Inc.
$53
Adaptive Biotechnologies Corporation
$48
JAZZ PHARMACEUTICALS INC.
$42
Eisai Inc.
$41
Rigel Pharmaceuticals, Inc.
$34
ARRAY BIOPHARMA INC
$33
Genentech USA, Inc.
$32
EMD Serono, Inc.
$32
Pharmacosmos Therapeutics Inc.
$31
Blueprint Medicines Corporation
$30
Boston Scientific Corporation
$28
Kite Pharma, Inc.
$27
Mirati Therapeutics, Inc.
$26
Regeneron Healthcare Solutions, Inc.
$25
CTI BioPharma Corp.
$25
Stemline Therapeutics Inc.
$25
TerSera Therapeutics LLC
$24
ABBVIE INC.
$22
GlaxoSmithKline, LLC.
$21
Tempus AI, Inc
$21
Seagen Inc.
$20
Helsinn Therapeutics (U.S.), Inc.
$18
Tactile Systems Technology Inc
$13
Top 3 companies account for 27.6% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · ALUNBRIG · AYVAKIT · BESPONSA · BESREMI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · ENJAYMO · EPKINLY · Enhertu · FOTIVDA · Fabhalta · Flexitouch Plus · IBRANCE · IMBRUVICA · IMFINZI · Itovebi · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUMAKRAS · Lenvima · MONOFERRIC · NERLYNX · NINLARO · Nplate · OJJAARA · OPDIVO · OPDUALAG · Orserdu · PADCEV · PROMACTA · Padcev · Pomalyst · QINLOCK · REBLOZYL · Rezlidhia · SARCLISA · SCEMBLIX · TABRECTA · TALZENNA · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · Vectibix · Vonjo · XPOVIO · XT CDX · XTANDI · Xtandi · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $30 per 100 Medicare services performed
Looking for a medical oncology specialist in Pearland?
Compare medical oncologists in the Pearland area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
179
Per 100K population
46.9
County median income
$95,155
Nearest hospital
HCA HOUSTON HEALTHCARE PEARLAND
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sethi is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sethi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sethi performed 10,710 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sethi receive payments from pharmaceutical companies?
Yes. Dr. Sethi received a total of $3,530 from 43 companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sethi's costs compare to other medical oncologists in Pearland?
Dr. Sethi's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sethi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →